Psychological Signs in Patients with Polycystic Ovary Syndrome
AbstractObjective: PCOS is a multifaceted disorder with multiple potential risk factors (e.g. infertility, diabetes,cardiovascular disease and metabolic syndrome). PCOS affects quality of life and can worsen anxiety and depression either due to the features of PCOS or due to the diagnosis of a chronic disease. This study aimed to determine the risk factors of PCOS in a group of patients.Materials and methods: In this descriptive-analytic study, 81 patients with PCOS were studied in Vali-e-Asr Reproductive Health Research Center, Tehran, Iran. A questionnaire with items related to stress information was used for data collection. Stress symptoms were assessed using the Understanding Yourself standard questionnaire. Statistical analyses were performed using SPSS 13.0 (SPSS Inc., Chicago, ILL, USA). Data are presented as mean ± SD or as frequency with percentages. P-value less than 0.05 were considered as statistically significant.Results: The evaluation of psychological signs in 81 PCO patients and descriptive results showed that 8 (9.9%) had not any stress problem, 32 (39.5%) had neurotic stress, 29 (35.8%) had high level and 12 (14.8%) had extremely high level of stress. The age range of 26 years and more (P=0.023), touchy personality (P = 0.028) and acne (P = 0.015) related with high stress level. The odds of high level of anxiety in women with hirsutism was 3.1 (95%CI 1.00 to 9.59). The odds of high level of obsession in overweight patients was 3.2 (95%CI 1.12 to 9.234). The odds of high level of worrisome in patients with touchy personality was 3.4 (95%CI 1.10 to 11.19). Obsession score had a correlation with illness duration (r = -0.268, P = 0.038).Conclusion: These data showed that clinical signs of PCOS are the most closely associated with psychological distress and this has important implications for the diagnosis and treatment of disorders.
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544-51.
Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-6). Gynecol Endocrinol 2006; 22: 80-6.
Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006; 11: 613-25.
Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod 2009; 24: 1446-51.
Badavi A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011, 3: 25-35.
Farrell K, Antoni MH. Insulin resistance, obesity, inflammation,and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010; 94: 1565-74.
Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M.Quality of life of hirsute women.Postgrad Med J 1993; 69: 186-9.
Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998; 83: 1976-87.
Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, et al. The polycystic ovary syndrome health- related quality of life questionnaire (PCOSQ): a validation. Hum Reprod 2004; 19: 371-7.
Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004; 66: 356-62.
Scott KM, Bruffaerts R,Simon GE, Alonso J, Angermeyer M, de Girolamo G,et al.Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond) 2008; 32: 192-200.
Wiltink J, Beutel ME, Till Y, Ojeda FM, Wild PS, Munzel T, et al. Prevalence of distress, comorbid conditions and well being in the general population. J Affect Disord 2011; 130: 429-37.
Skilton MR, Moulin P,Terra JL, Bonnet F.Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007; 62: 1251-7.
Vanhala M, Jokelainen J,Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H.Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand 2009; 119: 137-42.
Pasco JA, Nicholson GC,Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, et al. Association of high- sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010; 197: 372-7.
Kitzinger C, Willmott J.The thief of womanhood’: women's experience of polycystic ovarian syndrome. Soc Sci Med 2002, 54: 349-61.
Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2002, 156: 556-60.
Trent ME, Rich M, Austin SB, Gordon CM. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003, 16: 33-7.
Trent ME, Austin SB, Rich M, Gordon CM.Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005, 5: 107-11.
Gambineri A, Pelusi C, Vicennati V, et al: Obesity and the polycystic ovary syndrome. Int J Obesity 2002,26: 883 –96.
Elsenbruch S. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Euro J Endocrinol 2005, 153: 853-60.
Dixon JB,Dixon ME, O’Brien PE. Depression in association with severe obesity. Arch Intern Med 2003,163: 2058 –65.
Adali E, Yildizhan R, Kurdoglui M, Kolusari A, Edirne T, Sahin HG, et al. The Relationship between clinicobiochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome. The Journal of International Medical Research 2008, 36: 1188 –96.
Elsenbruch S,Benson S, Hahn S, Tan S,Mann K, Pleger K, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod.2006; 21: 1092-9.
Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al. Depression in women with polycystic ovary syndrome: clinical and biochemicalcorrelates. J Affect Disord. 2003; 74: 299-304.
Hollinrake E, Abreu A, Maifeld M. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007, 87: 1369 –76.
Brown AJ.Depression and insulin resistance: applications to polycystic ovary syndrome. Clin Obstet Gynecol 2004, 47: 592 –6.
Roos C, Lidfeldt J, Agardh CD. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women’s Health in the Lund Area study. Metabolism 2007; 56: 825 –9.
Eggers S,Kirchengast S.The polycystic ovary syndrome a medical condition but also an important psychosocial problem. Coll Antropol 2001; 25: 673-85.
Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A.Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. J.Psychosom Obstet Gynaecol 2011, 32:104-11.
Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod2003; 19: 41 –7.
Berens LV. Understanding Yourself questionnaire.Translator: Rezakhani Z. Signet Publications; 2001.
Hirschberg AL. Polycystic ovary syndrome, obesity and reproductive implications. Womens Health (Lond Engl) 2009; 5: 529-42.
Shulman LH, DeRogatis L, Spielvogel R.Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol 1992; 27: 178 –81.
Weber B,Lewicka S, Deuschle M.Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrin 2000; 25:765 –71.
Moran LJ, Lombard CB, Lim S, Noakes M, Teede HJ.Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) 2010; 6: 271-83.
Benson S, Janssen OE, Hahn S. Obesity, depression,and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun 2008;22: 177 –184.
Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ,Sopko G, Braunstein GD,et al.Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008;93: 1276–84.
Barnard L, Ferriday D, Guenther N.Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279 –86.
Willmott J. The experiences of women with polycystic ovarian syndrome. Feminism Psychol 2000; 10: 107-16.
Kumarapeli V, Seneviratne Rde A, Wijeyaratne C.Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women. BJOG 2011; 118: 319-28.
Sundararaman PG, Shweta, Sridhar GR. Psychosocialaspects of women with polycystic ovary syndrome from south India. J Assoc Physicians India 2008; 56:945-8.
Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L.A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005; 152: 986-92.
Keegan A, Liao LM, Boyle M. Hirsutism: a psychological analysis. J Health Psychol 2003; 8: 327-45.
Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al.Quality of life,psychosocialwell-being and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocr Metab 2003; 88: 5801-7.